Free Trial
→ This Crypto Is Set to Explode in December (From Crypto 101 Media) (Ad) Free MLYS Stock Alerts

Mineralys Therapeutics (MLYS) Insider Trading & Ownership

Mineralys Therapeutics logo
$12.34 +0.51 (+4.31%)
(As of 12/20/2024 05:16 PM ET)
Compare

Mineralys Therapeutics (NASDAQ:MLYS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
33.24%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$7.50 M
Number Of
Insiders Selling
(Last 12 Months)
4
Amount Of
Insider Selling
(Last 12 Months)
$9.94 M
Get MLYS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MLYS Insider Buying and Selling by Quarter

Ad Crypto Swap Profits
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.
>> Register for the Workshop Now

Mineralys Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2024David Malcom RodmanInsiderSell25,482$15.03$382,994.46  
10/11/2024Adam Scott LevyCFOSell10,757$13.57$145,972.49  
10/11/2024Jon CongletonCEOSell15,271$13.52$206,463.92  
7/24/2024Brian Taylor SlingsbyDirectorSell550,000$13.05$7,177,500.00  
7/16/2024David Malcom RodmanInsiderSell525$15.00$7,875.00  
7/11/2024Adam Scott LevyCFOSell10,757$13.14$141,346.98  
7/11/2024Jon CongletonCEOSell15,746$13.34$210,051.64  
6/14/2024Jon CongletonCEOSell16,229$12.52$203,187.08  
6/12/2024Jon CongletonCEOSell16,607$12.77$212,071.39  
6/11/2024Adam Scott LevyCFOSell96,815$12.94$1,252,786.10  
5/9/2024David Malcom RodmanInsiderSell100$15.00$1,500.00  
2/12/2024Samsara Biocapital Gp, LlcMajor ShareholderBuy555,555$13.50$7,499,992.50  
(Data available from 1/1/2013 forward)

MLYS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Mineralys Therapeutics includes Adam Scott Levy, Brian Taylor Slingsby, David Malcom Rodman, Hbm Healthcare Investments (Ca, Jon Congleton, Ra Capital Management, L.P., and Samsara Biocapital Gp, Llc. Learn more on insiders at MLYS.

33.24% of Mineralys Therapeutics stock is owned by insiders. Learn more on MLYS's insider holdings.

The following insiders have purchased MLYS shares in the last 24 months: Adam Scott Levy ($100,000.00), Hbm Healthcare Investments (Ca ($5,000,000.00), Jon Congleton ($105,557.50), Ra Capital Management, L.P. ($20,000,000.00), and Samsara Biocapital Gp, Llc ($7,499,992.50).

Insiders have purchased a total of 2,135,055 MLYS shares in the last 24 months for a total of $32,705,550.00 bought.

The following insiders have sold MLYS shares in the last 24 months: Adam Scott Levy ($1,540,105.57), Brian Taylor Slingsby ($7,177,500.00), David Malcom Rodman ($2,404,705.17), and Jon Congleton ($831,774.03).

Insiders have sold a total of 915,380 Mineralys Therapeutics shares in the last 24 months for a total of $11,954,084.77 sold.

Mineralys Therapeutics Key Executives

  • Dr. Brian Taylor Slingsby M.D. (Age 47)
    M.P.H., Ph.D., Founder & Executive Chairman
    Compensation: $69.33k
    1 recent trades
  • Mr. Jon Congleton (Age 61)
    CEO & Director
    Compensation: $775.77k
    2 recent trades
  • Mr. Adam Scott Levy (Age 46)
    CFO & Secretary
    Compensation: $655.58k
    2 recent trades
  • Dr. David M. Rodman M.D. (Age 69)
    Chief Medical Officer
    Compensation: $726.95k
  • Ms. Cindy Berejikian
    Executive Vice President of Operations
  • Ms. Sarah Foster
    Vice President of Human Resources
  • Dr. Robert McKean Ph.D.
    Senior Vice President of CMC
  • Ms. Danielle Bradbury
    Senior Vice President of Quality Assurance
  • Mr. Jeffrey N. Fellows
    Senior Vice President of Regulatory Affairs
  • Ms. Jessica Ibbitson
    Senior Vice President of Clinical Operations

Related Companies
Insider Tracking Tools
Insider Trading By Country
Latest Articles

This page (NASDAQ:MLYS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners
Amazon coin set to soar 25X – starting December 16th?
This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...
True Market Insiders | Sponsored
Did You See Trump’s Bombshell Exec. Order 001?
Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."
Banyan Hill Publishing | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
Elon Musk’s chilling warning for humanity
The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...
The Freeport Society | Sponsored
Top Picks for Trump’s Pro-Crypto America
Coins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...
Crypto 101 Media | Sponsored
Vladimir Lenin was right…
The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...
Porter & Company | Sponsored